Literature DB >> 11773635

Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy.

S Morimoto1, Q-W Lu, K Harada, F Takahashi-Yanaga, R Minakami, M Ohta, T Sasaguri, I Ohtsuki.   

Abstract

A deletion mutation Delta K210 in cardiac troponin T (cTnT) was recently found to cause familial dilated cardiomyopathy (DCM). To explore the effect of this mutation on cardiac muscle contraction under physiological conditions, we determined the Ca(2+)-activated force generation in permeabilized rabbit cardiac muscle fibers into which the mutant and wild-type cTnTs were incorporated by using our TnT exchange technique. The free Ca(2+) concentrations required for the force generation were higher in the mutant cTnT-exchanged fibers than in the wild-type cTnT-exchanged ones, with no statistically significant differences in maximal force-generating capability and cooperativity. Exchanging the mutant cTnT into isolated cardiac myofibrils also increased the free Ca(2+) concentrations required for the activation of ATPase. In contrast, a deletion mutation Delta E160 in cTnT that causes familial hypertrophic cardiomyopathy (HCM) decreased the free Ca(2+) concentrations required for force generation, just as in the case of the other HCM-causing mutations in cTnT. The results indicate that cTnT mutations found in the two distinct forms of cardiomyopathy (i.e., HCM and DCM) change the Ca(2+) sensitivity of cardiac muscle contraction in opposite directions. The present study strongly suggests that Ca(2+) desensitization of force generation in sarcomere is a primary mechanism for the pathogenesis of DCM associated with the deletion mutation Delta K210 in cTnT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773635      PMCID: PMC117405          DOI: 10.1073/pnas.022628899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.

Authors:  D Szczesna; R Zhang; J Zhao; M Jones; G Guzman; J D Potter
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

2.  Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.

Authors:  K Elliott; H Watkins; C S Redwood
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

3.  Functional consequences of the deletion mutation deltaGlu160 in human cardiac troponin T.

Authors:  K Harada; F Takahashi-Yanaga; R Minakami; S Morimoto; I Ohtsuki
Journal:  J Biochem       Date:  2000-02       Impact factor: 3.387

4.  Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy.

Authors:  F Yanaga; S Morimoto; I Ohtsuki
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

5.  Desmin mutation responsible for idiopathic dilated cardiomyopathy.

Authors:  D Li; T Tapscoft; O Gonzalez; P E Burch; M A Quiñones; W A Zoghbi; R Hill; L L Bachinski; D L Mann; R Roberts
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

6.  Functional consequences of a carboxyl terminal missense mutation Arg278Cys in human cardiac troponin T.

Authors:  S Morimoto; H Nakaura; F Yanaga; I Ohtsuki
Journal:  Biochem Biophys Res Commun       Date:  1999-07-22       Impact factor: 3.575

7.  Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.

Authors:  C Redwood; K Lohmann; W Bing; G M Esposito; K Elliott; H Abdulrazzak; A Knott; I Purcell; S Marston; H Watkins
Journal:  Circ Res       Date:  2000-06-09       Impact factor: 17.367

8.  Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex.

Authors:  A Sakamoto; K Ono; M Abe; G Jasmin; T Eki; Y Murakami; T Masaki; T Toyo-oka; F Hanaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

9.  Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy.

Authors:  S Morimoto; F Yanaga; R Minakami; I Ohtsuki
Journal:  Am J Physiol       Date:  1998-07

10.  The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies.

Authors:  P D'Adamo; L Fassone; A Gedeon; E A Janssen; S Bione; P A Bolhuis; P G Barth; M Wilson; E Haan; K H Orstavik; M A Patton; A J Green; E Zammarchi; M A Donati; D Toniolo
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

View more
  63 in total

Review 1.  Where Does Inflammation Fit?

Authors:  Luigi M Biasucci; Giulio La Rosa; Daniela Pedicino; Alessia D'Aiello; Mattia Galli; Giovanna Liuzzo
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

2.  Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.

Authors:  Neal K Lakdawala; Lisa Dellefave; Charles S Redwood; Elizabeth Sparks; Allison L Cirino; Steve Depalma; Steven D Colan; Birgit Funke; Rebekah S Zimmerman; Paul Robinson; Hugh Watkins; Christine E Seidman; J G Seidman; Elizabeth M McNally; Carolyn Y Ho
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

3.  Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.

Authors:  Jose Renato Pinto; Jill D Siegfried; Michelle S Parvatiyar; Duanxiang Li; Nadine Norton; Michelle A Jones; Jingsheng Liang; James D Potter; Ray E Hershberger
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

Review 4.  Hypertrophic cardiomyopathy: from genetics to treatment.

Authors:  Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

Review 5.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 6.  Structural based insights into the role of troponin in cardiac muscle pathophysiology.

Authors:  Monica X Li; Xu Wang; Brian D Sykes
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

7.  On mice, rabbits, and human heart failure.

Authors:  A J Marian
Journal:  Circulation       Date:  2005-05-10       Impact factor: 29.690

8.  Late onset sporadic dilated cardiomyopathy caused by a cardiac troponin T mutation.

Authors:  Ana Morales; Jose Renato Pinto; Jill D Siegfried; Duanxiang Li; Nadine Norton; Mark Hofmeyer; Marta Vallin; Azorides R Morales; James D Potter; Ray E Hershberger
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

9.  Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy.

Authors:  E Otten; R H Lekanne Dit Deprez; M M Weiss; M van Slegtenhorst; M Joosten; J J van der Smagt; N de Jonge; W S Kerstjens-Frederikse; M T R Roofthooft; A H M M Balk; M P van den Berg; J S Ruiter; J P van Tintelen
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

10.  A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.

Authors:  K M Broughton; J Li; E Sarmah; C M Warren; Y-H Lin; M P Henze; V Sanchez-Freire; R J Solaro; B Russell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.